AQR Capital Management LLC grew its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 12.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,370,813 shares of the real estate investment trust's stock after purchasing an additional 147,955 shares during the period. AQR Capital Management LLC owned approximately 0.58% of Sabra Healthcare REIT worth $23,948,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in the stock. SVB Wealth LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $34,000. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 1,621 shares during the period. Wealth Preservation Advisors LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $38,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Sabra Healthcare REIT by 61.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after acquiring an additional 1,065 shares during the period. Finally, Assetmark Inc. grew its holdings in shares of Sabra Healthcare REIT by 37.8% in the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after acquiring an additional 989 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Sabra Healthcare REIT Price Performance
NASDAQ:SBRA traded down $0.08 during trading hours on Friday, reaching $19.05. 1,519,531 shares of the company traded hands, compared to its average volume of 2,188,764. The firm's 50-day moving average is $18.68 and its 200-day moving average is $17.98. The stock has a market cap of $4.57 billion, a P/E ratio of 25.07, a P/E/G ratio of 1.53 and a beta of 0.88. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same quarter last year, the firm earned $0.36 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on SBRA. JMP Securities upped their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. BMO Capital Markets lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. Finally, Truist Financial increased their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $20.83.
View Our Latest Analysis on Sabra Healthcare REIT
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.